Please login to the form below

Not currently logged in
Email:
Password:

Vanda Pharmaceuticals

This page shows the latest Vanda Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

BMS' Opdivo backed as melanoma therapy in EU

BMS' Opdivo backed as melanoma therapy in EU

Vanda Pharmaceuticals got the go-ahead for Hetlioz (tasimelteon) for the treatment of non-24-hour sleep wake disorder in totally blind adults - which was approved in the US last year -

Latest news

  • FDA approves sleep disorder drug for blind people FDA approves sleep disorder drug for blind people

    Vanda Pharmaceuticals wins backing for Hetlioz to improve a person’s body clock. ... Vanda Pharmaceuticals is now allowed to market its drug Hetlioz (tasimelteon) to treat a condition called non-24-hour sleep-wake disorder, which causes problems in the

  • FDA panel backs sleep pattern drug for blind FDA panel backs sleep pattern drug for blind

    Vanda’s Hetlioz intended to improve circadian rhythms in people who cannot see. ... A Food Drug and Administration (FDA) advisory committee voted unanimously to recommend approval of Vanda Pharmaceuticals' Hetlioz (tasimelteon) for non-24-hour disorder

  • Vanda withdraws EU application for schizophrenia drug Vanda withdraws EU application for schizophrenia drug

    CHMP had previously refused to back the approval of Fanaptum. Vanda Pharmaceuticals has decided to withdraw its EU marketing application for the use of Fanaptum to treat schizophrenia. ... Vanda requested a re-examination of the data last month, but has

  • FDA starts review of Lundbeck’s antipsychotic aripiprazole

    Novartis and Vanda Pharmaceuticals also have a depot formulation of iloperidone in trials which should reach the market in 2015.

  • FDA scientist charged with insider trading

    The criminal complaint charges both men with conspiracy to commit securities and wire fraud relating to their trading of stock in Clinical Data, Vanda Pharmaceuticals, Progenics Pharmaceuticals, Middlebrook Pharmaceuticals and Momenta ... Pharmaceuticals.

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health are expert navigators, helping healthcare clients uncover hidden insights, explore scientific options and make difficult strategic choices...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics